ESR1 and breast carcinoma: The second mechanism could involve ER levels being a marker of current estrogen levels; estrogen levels themselves could increase breast cancer risk via ER-dependent stimulation of proliferation or via DNA damage through ER-independent mechanisms by various estrogen metabolites [1,2].